Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15583DOI Listing

Publication Analysis

Top Keywords

letter histology
4
histology relevant
4
relevant risk
4
risk stratification
4
stratification primary
4
primary biliary
4
biliary cholangitis
4
letter
1
relevant
1
risk
1

Similar Publications

Primary adrenal NK/T lymphoma: A case report of a rare tumor.

J Cancer Res Ther

September 2025

Department of Urology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Organ Transplantation and Nephrosis, Shandong Institute of Nephrology, Jinan, Shandong, China.

Natural killer/T-cell lymphoma (NKTCL) is a subtype of non-Hodgkin's lymphoma characterized by rapid progression. It infrequently involves the adrenal glands and exhibits swift advancement. A 52-year-old woman was admitted to the hospital with bilateral renal pain.

View Article and Find Full Text PDF

Complete response in a patient with metastatic metaplastic breast cancer treated with immune checkpoint inhibitor and chemotherapy: A case report and a review of the literature.

J Cancer Res Ther

September 2025

Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China.

Metaplastic breast cancer (MpBC) is a rare subtype of breast cancer characterized by poor prognosis and lack of treatment guidance. It is notably resistant to conventional chemotherapy. Currently, immunotherapy is becoming a promising option for multiple tumor types, including triple-negative breast cancer.

View Article and Find Full Text PDF

Traditional tumor-node-metastasis staging overlooks key prognostic factors such as inflammation and nutrition, limiting individualized treatment in colorectal cancer. Integrating biochemical markers with artificial intelligence can significantly improve survival prediction and treatment personalization by analyzing complex, multimodal data. This evolving approach holds transformative potential for precision oncology.

View Article and Find Full Text PDF